| VIVORYON THERAP. EO-,01 |
| Niederlande |
| Gesundheit |
| NL00150002Q7 / A2QJV6 |
| 05Y (Frankfurt) |
| FRA:05Y, ETR:05Y, 05Y:GR |
| - |
| https://www.vivoryon.com/ |
|
Vivoryon Therapeutics N.V. is a clinical-stage biopharmaceutical company specializing in the discovery, development, and potential commercialization of small molecule-based medicines that modulate the activity and stability of pathologically altered ..
>Volltext.. |
| 33.84 Mio. EUR |
| 28.34 Mio. EUR |
| - |
| -9.13 Mio. EUR |
| -8.95 Mio. EUR |
| -0.33 EUR |
| 0.11 Mio. EUR |
| 5.68 Mio. EUR |
| -8.55 Mio. EUR |
| 6.71 |
| - |
| 56.96% |
| - |
| - |
| - |
| - |
| VIVORYON |
| 17.06.26 |
|